Better Therapeutics, a prescription digital therapeutic startup, has collaborated with Glooko, a remote patient monitoring and diabetes care platform. The partnership will focus on integrating Better Therapeutics' recently launched AspyreRx , a digital behavioral treatment for type 2 diabetes (T2D), into Glooko's platform.
The collaboration will identify potential patients for AspyreRx treatment and enable healthcare professionals to prescribe and monitor digital therapeutics.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.